125 related articles for article (PubMed ID: 15609099)
1. Expression of the proliferation-associated nuclear protein MIB-1 and its relationship with microvascular density in bone marrow biopsies of patients with myelodysplastic syndromes.
Alexandrakis MG; Passam FH; Kyriakou DS; Dambaki C; Katrinakis G; Tsirakis G; Konsolas J; Stathopoulos EN
J Mol Histol; 2004 Nov; 35(8-9):857-63. PubMed ID: 15609099
[TBL] [Abstract][Full Text] [Related]
2. Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.
Alexandrakis MG; Passam FH; Pappa CA; Sfiridaki K; Tsirakis G; Damilakis J; Stathopoulos EN; Kyriakou DS
Leuk Res; 2005 Jan; 29(1):41-6. PubMed ID: 15541473
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
Lundberg LG; Hellström-Lindberg E; Kanter-Lewensohn L; Lerner R; Palmblad J
Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in myelodysplastic syndromes (MDS) in Indian patients.
Dutta P; Bhattacharya J; Karak AK; Gupta M; Chatterjee T; Srinivas U; Mishra P; Saxena R
Indian J Pathol Microbiol; 2006 Apr; 49(2):218-20. PubMed ID: 16933718
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
7. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
[TBL] [Abstract][Full Text] [Related]
9. Serum evaluation of angiogenic cytokine basic fibroblast growth factor, hepatocyte growth factor and TNF-alpha in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.
Alexandrakis MG; Passam FH; Pappa CA; Damilakis J; Tsirakis G; Kandidaki E; Passam AM; Stathopoulos EN; Kyriakou DS
Int J Immunopathol Pharmacol; 2005; 18(2):287-95. PubMed ID: 15888251
[TBL] [Abstract][Full Text] [Related]
10. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
Zou WR; Liu T; Meng WT; Yu J; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis in myelodysplastic syndromes.
Pruneri G; Bertolini F; Soligo D; Carboni N; Cortelezzi A; Ferrucci PF; Buffa R; Lambertenghi-Deliliers G; Pezzella F
Br J Cancer; 1999 Dec; 81(8):1398-401. PubMed ID: 10604739
[TBL] [Abstract][Full Text] [Related]
12. Prognostic evaluation of the microvascular network in myelodysplastic syndromes.
Korkolopoulou P; Apostolidou E; Pavlopoulos PM; Kavantzas N; Vyniou N; Thymara I; Terpos E; Patsouris E; Yataganas X; Davaris P
Leukemia; 2001 Sep; 15(9):1369-76. PubMed ID: 11516097
[TBL] [Abstract][Full Text] [Related]
13. [Correlation of stromal cell derived factor-1 with angiogenesis and cell apoptosis in myelodysplastic syndromes].
Zhi YQ; Zhang YZ; Zhao HF; Zhao DD; Xia B; Wu XX; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1438-42. PubMed ID: 22169299
[TBL] [Abstract][Full Text] [Related]
14. Increased microvascular network in bone marrow of HIV-positive haemophilic patients.
Patsouris E; Katsarou O; Korkolopoulou P; Kotsi P; Kouramba A; Androulaki A; Karafoulidou A
HIV Med; 2004 Jan; 5(1):18-25. PubMed ID: 14731165
[TBL] [Abstract][Full Text] [Related]
15. CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes.
Soligo DA; Oriani A; Annaloro C; Cortelezzi A; Calori R; Pozzoli E; Nosella D; Orazi A; Deliliers GL
Am J Hematol; 1994 May; 46(1):9-17. PubMed ID: 7514357
[TBL] [Abstract][Full Text] [Related]
16. Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia.
Patsouris E; Korkolopoulou P; Androulaki A; Douzinas E; Kosmopoulou O; Kordossis T
Pathology; 2003 Aug; 35(4):330-5. PubMed ID: 12959769
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and survival in patients with myelodysplastic syndrome.
Savic A; Cemerikic-Martinovic V; Dovat S; Rajic N; Urosevic I; Sekulic B; Kvrgic V; Popovic S
Pathol Oncol Res; 2012 Jul; 18(3):681-90. PubMed ID: 22270865
[TBL] [Abstract][Full Text] [Related]
18. CD34 immunohistochemical staining of bone marrow biopsies in myelodysplastic syndromes.
Min YH; Lee ST; Min DW; Kim TS; Lee CH; Lee BK; Hahn JS; Ko YW
Yonsei Med J; 1995 Mar; 36(1):1-8. PubMed ID: 7537931
[TBL] [Abstract][Full Text] [Related]
19. Apparent expansion of CD34+ cells during the evolution of myelodysplastic syndromes to acute myeloid leukemia.
Span LF; Dar SE; Shetty V; Mundle SD; Broady-Robinson L; Alvi S; Raymakers RA; de Witte T; Raza A
Leukemia; 1998 Nov; 12(11):1685-95. PubMed ID: 9823942
[TBL] [Abstract][Full Text] [Related]
20. Ploidy Analysis and Ki-67 Expression in Myelodysplastic Syndromes.
Ben-Ezra JM; Trinh K; Harris AC; Kornstein MJ
Hematology; 1998; 3(3):215-22. PubMed ID: 27416530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]